First Trust Exchange-Traded Fund VIII First Trust Active Global Quality Income ETF (ARCA: AGQI)

에 대한 최신 뉴스 First Trust Exchange-Traded Fund VIII First Trust Active Global Quality Income ETF (ARCA:AGQI)

Technology

Consumer Defensive

Financial Services

Communication Services

Industrials

Consumer Cyclical

Other

Healthcare

Energy

Utilities

Basic Materials

Under normal market conditions, the Fund seeks to invest primarily in income-producing equity securities. Such equity securities may include common stock, depositary receipts (including American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs)), preferred securities and real estate investment trusts (REITs). The Fund invests in U.S. and non-U.S. issuers and will typically invest at least 40 percent of its net assets in securities of issuers or companies that are economically tied to different countries throughout the world, excluding the United States. An issuer is deemed to be economically tied to a country or countries outside of the United States if one or more of the following tests are met: (i) the issuer is organized in, or its primary business office or principal trading market of its equity is located in, a country outside of the United States; (ii) a majority of the issuers revenues are derived from outside of the United States; or (iii) a majority of the issuers assets are located outside of the United States. The Fund has no specific policy on the number of different countries in which it will invest but intends to invest in at least three different countries. The Fund may invest up to 20 percent of its net assets in emerging market countries at time of purchase.

Microsoft Corp

Taiwan Semiconductor Manufacturing 59

R E L X P L C

TotalEnergies SE SPONSORED ADS

Merck & Co. Inc

Schneider Electric Se

Coca-cola Co (ko)

Sony Corporation

Procter & Gamble Company

Medtronic Plc

Nordea Bank Abp

Compagnie Generale Des Etablissements Michelin Eur2

Chevron Corp.

Carlsberg A/S (Class B)

First Trust Active Global Quality Income ETF

TSMC stock

Asia

Equities

News

Global

Markets

Tech

ETFs

AAPL

First Trust Exchange-Traded Fund VIII First Trust Active Global Quality Income ETF

AGQI

CARZ

NVDA

QCOM

대만 반도체 제조(TSMC)(NYSE:TSM)와 관련된 인기 있는 차익 거래(arbitrage trade)는 자사의 대만 주식 대비 미국 주식 프리미엄이 15년 최고치에 도달하면서 예상치 못한 어려움을 야기하고 있다. 사건의 전말 (What Happened): 대만 주식에 대한 TSMC의 미국 증권예탁증서(ADR)의 프리미엄은 이번 분기에 22%로 급등했는데, 이는 2009년 이후 가장 높은 평균치이라고 블룸버그가 월요일에 보도했다. 이러한 급등은 인공 지능(AI)에 대한 미국의 지속적인 열광에 기인한다.

미국 주식 프리미엄이 15년 최고치를 기록하면서 TSMC 차익 거래가 어려움에 직면

Barcelona,,Spain.,November,28,,2022:,Microchips,With,The,Tsmc,Logo

Media

AMZN

애플, 엔비디아는 AI 수요 급증에 대만의 TSMC의 고급 칩으로 미래 확보

<a href="https://www.nytimes.com/2025/05/22/climate/senate-republicans-electric-vehicles-california.html" title="https://www.nytimes.com/2025/05/22/climate/senate-republicans-electric-vehicles-california.html">https://www.nytimes.com/2025/05/22/climate/senate-republicans-electric-vehicles-california.html</a>

Macro Economic Events

Politics

Economics

General

LCID

RIVN

STLA

TSLA

'Senate Republicans Kill California's Ban On Gas-Powered Cars' - NY Times

Barclays analyst Raimo Lenschow maintains Snowflake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) with a Overweight and raises the price target from $203 to $219.

Price Target

Analyst Ratings

SNOW

Barclays Maintains Overweight on Snowflake, Raises Price Target to $219

WIIM

Longevity Health Holdings, Inc. - Common Stock

XAGE

Longevity Health Holdings shares are trading higher after the company announced it will retain its Nasdaq listing to complete its merger with 20/20 Biolabs.

Renovaro Inc. (NASDAQ:<a href="https://www.benzinga.com/stock/RENB#NASDAQ">RENB</a>), a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today announced that it has received a ruling to expedite a trial in 2025 for the lawsuit it filed on May 9, 2025, in the Delaware Court of Chancery against Predictive Oncology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POAI#NASDAQ">POAI</a>), seeking to enforce a binding merger agreement executed on January 1, 2025.
According to the Verified Complaint, the companies entered into a legally binding Letter Agreement pursuant to which Predictive Oncology would merge into Renovaro in exchange for a newly created class of preferred stock. Following the public disclosure of the agreement in a Form 8-K filed by POAI on January 6, 2025, POAI's stock price rose by more than 50%.
Renovaro alleges that Predictive Oncology breached the agreement's exclusivity and good faith negotiation provisions by conducting a public offering of $545,000 in securities on February 19, 2025—despite contractual restrictions—and later attempting to terminate the agreement unilaterally on April 3, 2025, without engaging meaningfully in the negotiation of a definitive merger agreement.
The litigation seeks specific performance, injunctive relief, and damages for the alleged breaches. The case is pending in the Delaware Court of Chancery under Case No. 2025-0509.

POAI

RENB

Renovaro Receives Ruling To Expedite Trial In 2025 For Lawsuit It Filed On May 9, 2025, In Delaware Court Of Chancery Against Predictive Oncology Seeking To Enforce Binding Merger Agreement Executed On January 1, 2025

Avalanche (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/avax/usd">AVAX</a>) jumped 8.46% to $25.13 Thursday morning, riding a broader cryptocurrency rally fueled by Bitcoin's surge to a record $111,544. The bullish sentiment follows strong institutional inflows into <a href="https://www.benzinga.com/money/best-spot-bitcoin-etfs">crypto ETFs</a>, a tightening Bitcoin supply post-halving and dovish macroeconomic signals.
What To Know: AVAX is the native token of the Avalanche blockchain, a high-speed, low-cost platform for decentralized applications and custom blockchain networks. Known for its scalability and eco-friendly consensus mechanism, Avalanche aims to rival Ethereum by supporting DeFi, NFTs, and enterprise applications.
Bitcoin&#8217;s rise has lifted the broader market, with Ethereum, Solana, XRP and BNB all posting gains between 3% and 6%. Analysts <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45562596/bitcoin-breaks-111000-as-experts-hail-regime-shift">say</a> the momentum is driven by spot demand, not leverage, highlighting a shift toward institutional adoption, aided by progress on U.S. crypto regulation.
Still, experts caution the market is nearing "<a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45562596/bitcoin-breaks-111000-as-experts-hail-regime-shift">extreme greed</a>," with sentiment at 72, and warn of possible pullbacks amid bond market volatility. Long-term risks also loom, including threats from quantum computing that could challenge crypto security if not addressed.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/05/45564098/bitcoin-mining-stocks-mara-holdings-riot-cleanspark-surge-as-bitcoin-climbs-to-new-highs-whats-going-on">Bitcoin Mining Stocks MARA Holdings, Riot, CleanSpark Surge As Bitcoin Climbs To New Highs: What&#8217;s Going On?</a>

$AVAX

Avalanche (AVAX) Rises Amid Crypto Market Surge: What's Going On?

JMP Securities analyst Patrick Walravens reiterates Zoom Communications (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>) from Market Perform to Market Perform.

Reiteration

JMP Securities Reiterates Market Perform on Zoom Communicationsto Market Perform

<a href="https://scr.zacks.com/files/News/2025/Zacks_SCR_Research_05222025_MTVA_Bautz.pdf" title="https://scr.zacks.com/files/News/2025/Zacks_SCR_Research_05222025_MTVA_Bautz.pdf">https://scr.zacks.com/files/News/2025/Zacks_SCR_Research_05222025_MTVA_Bautz.pdf</a>

Trading Ideas

MTVA

Watching MetaVia; Zacks Small-Cap Research Gives Stock $21 Price Valuation

JMP Securities analyst Andrew Boone reiterates Wix.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WIX#NASDAQ">WIX</a>) with a Market Outperform and maintains $250 price target.

JMP Securities Reiterates Market Outperform on Wix.com, Maintains $250 Price Target

Evercore ISI Group analyst Stephen Kim maintains Toll Brothers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOL#NYSE">TOL</a>) with a Outperform and raises the price target from $167 to $169.

Evercore ISI Group Maintains Outperform on Toll Brothers, Raises Price Target to $169

Evercore ISI Group analyst Kirk Materne maintains Snowflake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) with a Outperform and raises the price target from $200 to $232.

Evercore ISI Group Maintains Outperform on Snowflake, Raises Price Target to $232

Intel (INTC) on Thursday introduced its latest central processing units for servers, one of which landed a spot in Nvidia's (NVDA) DGX B300 artificial intelligence computer. But Intel stock wavered on Thursday.
Intel unveiled three new additions to its Intel Xeon 6 series of CPUs, which are designed to manage advanced graphics processing unit (GPU)-powered AI systems.
One of the new processors serves as the host CPU for Nvidia's DGX B300, the AI leader's latest generation of AI-accelerated systems.
Intel's Xeon 6 processors use a technology called Priority Core Turbo that dynamically adjusts workloads between high-priority compute cores and low-priority cores for maximum efficiency.
"We're thrilled to deepen our collaboration with Nvidia to deliver one of the industry's highest-performing AI systems, helping accelerate AI adoption across industries," Karin Eibschitz Segal, corporate vice president and interim general manager of Intel's Data Center Group, said in a news release.

INTC

'Intel Scores Slot In Nvidia Data Center AI System; Intel Introduced Its Latest Central Processing Units For Servers, One Of Which Landed A Spot In Nvidia's DGX B300 Artificial Intelligence Computer'

<a href="https://www.theinformation.com/articles/jpmorgan-lend-7-billion-openai-data-center">https://www.theinformation.com/articles/jpmorgan-lend-7-billion-openai-data-center</a>

MSFT

'JPMorgan to Lend More Than $7 Billion For OpenAI Data Center'- The Information

Jones Trading analyst Soumit Roy initiates coverage on Protara Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TARA#NASDAQ">TARA</a>) with a Buy rating and announces Price Target of $21.

Initiation

TARA

Jones Trading Initiates Coverage On Protara Therapeutics with Buy Rating, Announces Price Target of $21

Evercore ISI Group analyst Omar Saad maintains Canada Goose Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOOS#NYSE">GOOS</a>) with a In-Line and raises the price target from $10 to $11.

GOOS

Evercore ISI Group Maintains In-Line on Canada Goose Hldgs, Raises Price Target to $11

Whales with a lot of money to spend have taken a noticeably bearish stance on UnitedHealth Group.
Looking at options history for UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) we detected 38 trades.
If we consider the specifics of each trade, it is accurate to state that 36% of the investors opened trades with bullish expectations and 50% with bearish.
From the overall spotted trades, 16 are puts, for a total amount of $702,786 and 22, calls, for a total amount of $1,027,888.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $220.0 to $415.0 for UnitedHealth Group over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of UnitedHealth Group stands at 2360.9, with a total volume reaching 33,183.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in UnitedHealth Group, situated within the strike price corridor from $220.0 to $415.0, throughout the last 30 days.
<h3>UnitedHealth Group Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747926192_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$10.4</td>
<td>$10.0</td>
<td>$10.4</td>
<td>$350.00</td>
<td>$125.8K</td>
<td>6.0K</td>
<td>504</td>
</tr>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/27/25</td>
<td>$19.75</td>
<td>$19.5</td>
<td>$19.5</td>
<td>$300.00</td>
<td>$87.7K</td>
<td>630</td>
<td>112</td>
</tr>
<tr>
<td>UNH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/30/25</td>
<td>$12.65</td>
<td>$11.8</td>
<td>$11.8</td>
<td>$302.50</td>
<td>$85.0K</td>
<td>271</td>
<td>23</td>
</tr>
<tr>
<td>UNH</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$81.2</td>
<td>$78.4</td>
<td>$81.2</td>
<td>$350.00</td>
<td>$81.2K</td>
<td>552</td>
<td>21</td>
</tr>
<tr>
<td>UNH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/23/25</td>
<td>$7.95</td>
<td>$7.9</td>
<td>$7.9</td>
<td>$300.00</td>
<td>$79.0K</td>
<td>6.1K</td>
<td>1.9K</td>
</tr>
</tbody>
</table>

<h3>About UnitedHealth Group</h3>
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
After a thorough review of the options trading surrounding UnitedHealth Group, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of UnitedHealth Group</h3>
<ul>
<li>Currently trading with a volume of 12,416,542, the UNH's price is down by -1.44%, now at $298.61. </li>
<li>RSI readings suggest the stock is currently may be oversold.</li>
<li>Anticipated earnings release is in 54 days.</li>
</ul>
<h3>What The Experts Say On UnitedHealth Group</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $424.2.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Morgan Stanley keeps a Overweight rating on UnitedHealth Group with a target price of $374. 
&#x2A; An analyst from Baird persists with their Outperform rating on UnitedHealth Group, maintaining a target price of $510. 
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Overweight rating on UnitedHealth Group with a target price of $362. 
&#x2A; An analyst from RBC Capital has decided to maintain their Outperform rating on UnitedHealth Group, which currently sits at a price target of $525. 
&#x2A; In a cautious move, an analyst from B of A Securities downgraded its rating to Neutral, setting a price target of $350. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest UnitedHealth Group options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Options

Behind the Scenes of UnitedHealth Group's Latest Options Trends

Deep-pocketed investors have adopted a bearish approach towards Tempus AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in TEM usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 12 extraordinary options activities for Tempus AI. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 25% leaning bullish and 41% bearish. Among these notable options, 5 are puts, totaling $286,832, and 7 are calls, amounting to $345,383.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $20.0 to $100.0 for Tempus AI over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Tempus AI's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Tempus AI's whale activity within a strike price range from $20.0 to $100.0 in the last 30 days. 
<h3>Tempus AI Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747926188_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TEM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$21.5</td>
<td>$20.9</td>
<td>$21.3</td>
<td>$45.00</td>
<td>$106.5K</td>
<td>3.7K</td>
<td align="right">50</td>
</tr>
<tr>
<td>TEM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/17/25</td>
<td>$4.4</td>
<td>$4.2</td>
<td>$4.4</td>
<td>$100.00</td>
<td>$87.1K</td>
<td>1.1K</td>
<td align="right">204</td>
</tr>
<tr>
<td>TEM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$19.2</td>
<td>$18.1</td>
<td>$18.68</td>
<td>$75.00</td>
<td>$78.7K</td>
<td>106</td>
<td align="right">10</td>
</tr>
<tr>
<td>TEM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$3.6</td>
<td>$3.4</td>
<td>$3.6</td>
<td>$53.00</td>
<td>$69.4K</td>
<td>111</td>
<td align="right">36</td>
</tr>
<tr>
<td>TEM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/30/25</td>
<td>$2.35</td>
<td>$2.2</td>
<td>$2.3</td>
<td>$58.00</td>
<td>$69.0K</td>
<td>250</td>
<td align="right">500</td>
</tr>
</tbody>
</table>

<h3>About Tempus AI</h3>
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
<h3>Where Is Tempus AI Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 5,321,018, the TEM's price is up by 2.89%, now at $59.82. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 75 days.</li>
</ul>
<h3>What The Experts Say On Tempus AI</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $68.6.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from Needham downgraded its rating to Buy, setting a price target of $70. 
&#x2A; In a cautious move, an analyst from Needham downgraded its rating to Buy, setting a price target of $70. 
&#x2A; Maintaining their stance, an analyst from Piper Sandler continues to hold a Neutral rating for Tempus AI, targeting a price of $70. 
&#x2A; An analyst from B of A Securities has decided to maintain their Neutral rating on Tempus AI, which currently sits at a price target of $68. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Overweight rating on Tempus AI, which currently sits at a price target of $65. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Tempus AI, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Looking At Tempus AI's Recent Unusual Options Activity

Investors with a lot of money to spend have taken a bullish stance on Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with NKE, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 18 uncommon options trades for Nike.
This isn't normal.
The overall sentiment of these big-money traders is split between 61% bullish and 38%, bearish.
Out of all of the special options we uncovered, 8 are puts, for a total amount of $675,040, and 10 are calls, for a total amount of $769,960.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $52.5 and $90.0 for Nike, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Nike options trades today is 6586.07 with a total volume of 5,391.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Nike's big money trades within a strike price range of $52.5 to $90.0 over the last 30 days.
<h3>Nike Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747926183_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NKE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$6.15</td>
<td>$6.05</td>
<td>$6.15</td>
<td>$65.00</td>
<td>$369.0K</td>
<td>3.8K</td>
<td align="right">7</td>
</tr>
<tr>
<td>NKE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$4.8</td>
<td>$4.7</td>
<td>$4.71</td>
<td>$60.00</td>
<td>$235.5K</td>
<td>11.2K</td>
<td align="right">527</td>
</tr>
<tr>
<td>NKE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$4.8</td>
<td>$4.7</td>
<td>$4.71</td>
<td>$60.00</td>
<td>$235.5K</td>
<td>11.2K</td>
<td align="right">500</td>
</tr>
<tr>
<td>NKE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$4.45</td>
<td>$4.4</td>
<td>$4.45</td>
<td>$70.00</td>
<td>$100.1K</td>
<td>10.8K</td>
<td align="right">2</td>
</tr>
<tr>
<td>NKE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$2.01</td>
<td>$2.0</td>
<td>$2.01</td>
<td>$90.00</td>
<td>$65.1K</td>
<td>548</td>
<td align="right">326</td>
</tr>
</tbody>
</table>

<h3>About Nike</h3>
Nike is the largest athletic footwear and apparel brand in the world. Key categories include basketball, running, and football (soccer). Footwear generates about two thirds of its sales. Its brands include Nike, Jordan (premium athletic footwear and clothing), and Converse (casual footwear). Nike sells products worldwide through company-owned stores, franchised stores, and third-party retailers. The firm also operates e-commerce platforms in more than 40 countries. Nearly all its production is outsourced to contract manufacturers in more than 30 countries. Nike was founded in 1964 and is based in Beaverton, Oregon.
After a thorough review of the options trading surrounding Nike, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is Nike Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 5,989,719, the NKE's price is up by 1.28%, now at $60.75. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 35 days.</li>
</ul>
<h3>What The Experts Say On Nike</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $61.2.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from JP Morgan persists with their Neutral rating on Nike, maintaining a target price of $56. 
&#x2A; An analyst from Wells Fargo downgraded its action to Equal-Weight with a price target of $55. 
&#x2A; An analyst from RBC Capital has decided to maintain their Sector Perform rating on Nike, which currently sits at a price target of $65. 
&#x2A; An analyst from Wells Fargo persists with their Equal-Weight rating on Nike, maintaining a target price of $60. 
&#x2A; An analyst from Telsey Advisory Group has decided to maintain their Market Perform rating on Nike, which currently sits at a price target of $70. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Nike options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

A Closer Look at Nike's Options Market Dynamics

Evercore ISI Group analyst Kirk Materne maintains Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) with a Outperform and raises the price target from $500 to $515.

Evercore ISI Group Maintains Outperform on Microsoft, Raises Price Target to $515

A notable insider purchase on May 21, was reported by Todd David Pearson, President &amp; COO at Saul Centers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFS#NYSE">BFS</a>), based on the most recent SEC filing.
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0000907254/000090725425000086//Archives/edgar/data/907254/000090725425000086/0000907254-25-000086-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday showed that Pearson purchased 1,523 shares of Saul Centers. The total transaction amounted to $50,428. 
Monitoring the market, Saul Centers's shares down by 0.0% at $32.88 during Thursday's morning.
<h3>Discovering Saul Centers: A Closer Look</h3>
Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: shopping centers, which contribute the maximum portion of total revenue; and mixed-use properties. Maximum tenants include grocery stores, discount department stores, and drug stores.
<h3>Financial Insights: Saul Centers</h3>
Revenue Growth: Saul Centers's revenue growth over a period of 3 months has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately 7.74%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Real Estate sector.
Exploring Profitability:
<ul>
<li>
Gross Margin: With a low gross margin of 69.76%, the company exhibits below-average profitability, signaling potential struggles in cost efficiency compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): Saul Centers's EPS reflects a decline, falling below the industry average with a current EPS of 0.29.
</li>
</ul>
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 10.77, caution is advised due to increased financial risk.
Analyzing Market Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: The current P/E ratio of 22.37 is below industry norms, indicating potential undervaluation and presenting an investment opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 2.9 is below industry norms, suggesting potential undervaluation and presenting an investment opportunity for those considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Saul Centers's EV/EBITDA ratio at 14.73 suggests potential undervaluation, falling below industry averages.
</li>
</ul>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Delving Into the Significance of Insider Transactions</h3>
Insider transactions contribute to decision-making but should be supplemented by a comprehensive investment analysis.
When discussing legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated in Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are required to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
A new purchase by a company insider is a indication that they anticipate the stock will rise.
On the other hand, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Transaction Codes Worth Your Attention</h3>
When analyzing transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> tend to focus on those in the open market, detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase,while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000907254">Check Out The Full List Of Saul Centers's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

President & COO Of Saul Centers Purchased $50K In Stock

On May 21, a substantial insider purchase was made by Deborah Caplan, Board Member at Mid-America Apartment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAA#NYSE">MAA</a>), as per the latest SEC filing.
What Happened: Caplan's recent move, as outlined in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000912595/000112760225015204//Archives/edgar/data/912595/000112760225015204/0001127602-25-015204-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday, involves purchasing 1,122 shares of Mid-America Apartment. The total transaction value is $179,912.
Tracking the Thursday's morning session, Mid-America Apartment shares are trading at $154.88, showing a down of 0.74%.
<h3>Discovering Mid-America Apartment: A Closer Look</h3>
Mid-America Apartment Communities Inc or MAA, is a real estate investment trust engaged in the acquisition, operation, and development of multifamily apartment communities located in the southeastern and southwestern United States. The company operates two reportable segments; Same Store includes communities that the Company has owned and have been stabilized for at least a full 12 months as of the first day of the calendar year and Non-Same Store and Other includes recently acquired communities, communities being developed or in lease-up, communities that have been disposed of or identified for disposition, communities that have experienced a casualty loss and stabilized communities that do not meet the requirements to be Same Store communities.
<h3>Mid-America Apartment: Financial Performance Dissected</h3>
Positive Revenue Trend: Examining Mid-America Apartment's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 1.04% as of 31 March, 2025, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Real Estate sector.
Insights into Profitability:
<ul>
<li>
Gross Margin: The company issues a cost efficiency warning with a low gross margin of 31.86%, indicating potential difficulties in maintaining profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Mid-America Apartment's EPS is a standout, portraying a positive bottom-line trend that exceeds the industry average with a current EPS of 1.55.
</li>
</ul>
Debt Management: Mid-America Apartment's debt-to-equity ratio is below the industry average at 0.84, reflecting a lower dependency on debt financing and a more conservative financial approach.
In-Depth Valuation Examination:
<ul>
<li>
Price to Earnings (P/E) Ratio: With a lower-than-average P/E ratio of 32.44, the stock indicates an attractive valuation, potentially presenting a buying opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 8.3, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an EV/EBITDA ratio lower than industry benchmarks at 17.2, Mid-America Apartment presents an attractive value opportunity.
</li>
</ul>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Uncovering the Importance of Insider Activity</h3>
Insider transactions contribute to decision-making but should be supplemented by a comprehensive investment analysis.
From a legal standpoint, the term "insider" pertains to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as outlined in Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and significant hedge funds. These insiders are mandated to inform the public of their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
A company insider's new purchase is a indicator of their positive anticipation for a rise in the stock.
While insider sells may not necessarily reflect a bearish view and can be motivated by various factors.
<h3>Important Transaction Codes</h3>
Surveying the realm of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often give prominence to those unfolding in the open market, systematically detailed in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C denotes the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000912595">Check Out The Full List Of Mid-America Apartment's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Deborah Caplan Boosts Confidence With $179K Purchase Of Mid-America Apartment Stock

대만 반도체 제조(TSMC)(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>)와 관련된 인기 있는 차익 거래(arbitrage trade)는 자사의 대만 주식 대비 미국 주식 프리미엄이 15년 최고치에 도달하면서 예상치 못한 어려움을 야기하고 있다.
사건의 전말 (What Happened): 대만 주식에 대한 TSMC의 미국 증권예탁증서(ADR)의 프리미엄은 이번 분기에 22%로 급등했는데, 이는 2009년 이후 가장 높은 평균치이라고 블룸버그가 월요일에 <a href="https://www.bloomberg.com/news/articles/2024-06-17/a-popular-arbitrage-trade-backfires-as-tsmc-frenzy-grows-in-us">보도</a>했다. 이러한 급등은 인공 지능(AI)에 대한 미국의 지속적인 열광에 기인한다.
미국 주식 프리미엄이 15년 최고치를 기록하면서 TSMC 차익 거래가 어려움에 직면: &#8216;AI 붐은 아직 끝나지 않았습니다&#8217;
올해 ADR이 66% 증가하고 타이베이 주가가 53% 상승했음에도 불구하고 둘 다 여전히 2021년 평가 최고치보다 낮은 수준으로 거래되고 있다. 외국인 투자자들에 대한 ADR의 접근성과 다양한 지수 및 상장지수 상품(ETP)에 대한 포함이 ADR의 뛰어난 성과에 기여했다.
차익거래는 사소한 가격 차이로 이익을 얻기 위해 서로 다른 시장에서 동일하거나 유사한 자산을 동시에 사고 파는 것을 의미한다. 이는 서로 다른 시장이나 형태에 걸쳐 동일하거나 유사한 금융 상품의 단기 가격 변동을 활용한다.
리서치 회사인 페리스코프 애널리틱스(Periscope Analytics)의 설립자인 브라이언 프레이타스(Brian Freitas)는 &#8220;이는 수요/공급 역학이다&#8221;라고 말했다. &#8220;모든 외국인 투자자들이 대만 주식을 보유할 수 있는 것은 아니기 때문에 ADR 보유를 선호한다. 게다가 ADR만 참조하는 지수들도 있으므로 ETF(상장지수펀드)가 결국은 미국 주식을 사게 되는 것이다.&#8221;
ADR은 역사적으로 미국 주식으로 전환하기 위해 특별 규제 승인이 필요한 대만 주식과 달리 대체성으로 인해 프리미엄으로 거래되었다. ADR은 또한 펀드매니저들이 많이 소유하고 있기 때문에 포지션을 더 늘리기가 어렵다.
픽텟 에셋 매니지먼트(Pictet Asset Management)의 아시아 특별 상황 책임자인 존 위타르(Jon Withaar)는 AI 부문이 여전히 강세를 유지하고 있으며 엔비디아(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)의 가치만 3조 달러가 넘는다고 언급했다. 대만 주식에 대한 ADR의 프리미엄은 이번 분기에 평균 거의 17%까지 상승하여 AI 붐이 계속되고 있음을 나타낸다.
위타르는 &#8220;AI 붐은 끝나지 않았다&#8221;고 말했다. &#8220;나는 크레센도가 확대되고 아마도 패닉이 풀릴 때까지 기다릴 수 있어 기쁘다.&#8221;
중요성 (Why It Matters): TSMC의 ADR은 전 세계적인 AI 열풍으로 인해 수요가 높아졌다. 애플(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), 퀄컴(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>), 엔비디아 및 어드밴스드 마이크로 디바이시스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>)와 같은 회사들은 AI 기술의 급속한 발전을 반영하여 <a href="https://www.benzinga.com/news/24/06/39310821/apple-nvidia-secure-future-with-taiwan-semis-advanced-chips-as-ai-demand-soars" target="_blank" rel="noopener" data-google-interstitial="false">2026년까지</a> TSMC의 3nm 칩 생산 공정을 거의 완전히 예약했다.
한편, TSMC의 유럽 자회사인 유럽 반도체 제조(ESMC)는 독일 및 기타 유럽 국가에서 약 <a href="https://www.benzinga.com/news/24/06/39288408/taiwan-semiconductors-european-subsidiary-to-hire-2k-employees-in-semiconductor-push" target="_blank" rel="noopener" data-google-interstitial="false">2,000</a>명의 직원을 고용할 계획이다. 이러한 움직임은 기업들이 AI 기술 발전에 대한 요구를 충족하기 위해 자원을 재분배함에 따라 기술 부문에서 일자리 감소 추세가 진행되는 가운데 나온 것이다.
지난 12개월 동안 TSMC의 주식은 64% 이상 상승했다. 투자자들은 First Trust Exchange-Traded Fund VIII First Trust Active Global Quality Income ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGQI#NYSE">AGQI</a>) 및 First Trust S-Network Electric &amp; Future Vehicle Ecosystem ETF(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARZ#NASDAQ">CARZ</a>)를 통해 반도체 부문에 노출될 수 있다.
가격 움직임: 금요일 미국 상장 TSMC의 주식은 0.23% 하락한 172.51달러에 마감했다. 올해 들어 지금까지 상승율은 69.91%로, 지난 1년 동안 증가율은 64.97%로 나타났다. 지난 5년 동안 이 주식은 355.89% 급등했다.
In comparison, TSMC's Taipei-listed stock has increased by 55.31% year to date, 57.98% over the past year, and 270.22% over the past five years, according to the <a href="https://pro.benzinga.com/dashboard" target="_blank" rel="noopener">data from Benzinga Pro</a>.
반면, <a href="https://pro.benzinga.com/dashboard">Benzinga Pro의 데이터</a>에 따르면 TSMC의 대만 주식은 올해 들어 55.31% 상승했고, 지난 1년 동안에는 57.98% 늘었으며, 지난 5년 동안 270.22% 상승했다.
Shutterstock 촬영 이미지

애플(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), 퀄컴(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>), 엔비디아(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) 및 어드밴스드 마이크로 디바이시스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>)는 인공 지능(AI) 열풍을 반영하여 2026년까지 대만반도체 제조(TSMC) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>)의 3nm 칩 생산 공정을 거의 완전히 예약했다.
이러한 수요 급증은 AI 기술의 급속한 발전을 반영하여 TSMC가 고급 제조 분야에서 더욱 혁신하도록 추진하고 있다고 테크노트(TechNode)가 <a href="https://technode.com/2024/06/12/apple-qualcomm-nvidia-amd-fully-book-tsmcs-3nm-capacity-until-2026/" target="_blank" rel="noreferrer noopener">보도</a>했다.
지난 분기 양산을 시작한 N3E는 AI 가속기, 고급 스마트폰, 데이터센터 등을 타깃으로 한다. 올해 말 대량 생산이 예정된 N3P는 모바일 기기와 가전제품을 대상으로 할 예정이다. 이 칩이 2026년에는 표준이 될 것으로 보인다.
이 증가하는 수요를 수용하기 위해 TSMC는 일부 5nm 장비를 전환하여 3nm 생산 능력을 향상시켜 잠재적으로 3nm 웨이퍼 생산량을 월 120,000~180,000개 사이로 늘릴 계획이다. TSMC 주식은 목요일에 상승했다..
이 계약 칩 제조업체는 대만을 넘어 <a href="https://www.benzinga.com/news/24/06/39293929/whats-going-on-with-nvidia-amd-stocks-on-wednesday" target="_blank" rel="noreferrer noopener">지리적 입지를 확장</a>하기 위해 계속 노력하고 있다. 최근 보도에 따르면 TSMC는 드레스덴 웨이퍼 공장 건설 계획에 맞춰 유럽에서 2,000명의 직원을 채용할 계획이라고 한다.
또한 TSMC는 1분기에 62%의 시장 점유율을 기록하며 중국의 선두 칩 제조업체인 중국 인터내셔널 반도체(SMIC)를 <a href="https://www.benzinga.com/government/24/06/39267332/taiwan-semi-outperforms-chinas-top-chipmaker-amid-tech-challenges" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">크게 이겼다</a>. AI에 대한 강렬한 수요가 조만간 사라지지 않음에 따라 5월에는 30%의 매출 성장을 기록하여 71억 달러에 이르렀다.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" class="wp-image-386123" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/13044941/newplot-25.png" sizes="(max-width: 750px) 100vw, 750px" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/13044941/newplot-25.png 750w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/13044941/newplot-25-300x260.png 300w" alt="" width="750" height="650" /></figure>
대만 반도체 주식은 지난 12개월 동안 62% 상승했다. 투자자들은 First Trust Exchange-Traded Fund VIII First Trust Active Global Quality Income ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGQI#NYSE">AGQI</a>) 및 First Trust S-Network Electric &amp; Future Vehicle Ecosystem ETF(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARZ#NASDAQ">CARZ</a>)를 통해 반도체 부문에 대한 노출을 얻을 수 있다.
가격 움직임: 목요일 뉴욕에 상장된 TSMC의 주식은 0.21% 상승해 172.91달러에 마감했다. 대만에 상장된 TSMC는 목요일 1.49% 오른 919.00대만 달러에 마쳒다.
면책 조항: 이 콘텐츠는 인공 지능 도구의 도움을 받아 제작된 부분이 포함되어 있으며 Benzinga 편집자들이 검토하고 게재했습니다.
사진: Shutterstock를 통해 Ivan Marc가 제공

Comments

First Trust Exchange-Traded Fund VIII First Trust Active Global Quality Income ETF

뉴스

에 대한 최신 뉴스 First Trust Exchange-Traded Fund VIII First Trust Active Global Quality Income ETF (ARCA:AGQI)

월요일, 6월 17, 2024

목요일, 6월 13, 2024

뉴스

파트너 / 기고자

벤징가 글로벌